Peptide-Drug Conjugate Self-Assembly Morphology Study

Experimental data investigates the self-assembly behaviors of a peptide-drug conjugate (Ket-L-VEVE). The study analyzes the influence of molecular design, assembly time, pH, and hydrogen bond inhibitors on aggregate morphology, which ranged from micelles to nanoribbons. The work, authored by Qin Fan and published in 2020, proposes a mechanism involving π-π stacking and hydrogen bonding.

Use Cases

• Analyze the relationship between pH levels and observed nanostructure morphology (e.g., micelle, nanoribbon).
• Model the impact of hydrogen bond inhibitor concentration on the transition between nanofiber and nanoribbon formations.
• Study the correlation between assembly time and the progression of aggregate shapes from micelles to nanoribbons.
• Investigate the role of the aromatic drug fragment (Ket) in π-π stacking interactions as an anchor for assembly.

Strengths

• Data is derived from controlled experiments on a specific peptide-drug conjugate (Ket-L-VEVE).
• Identifies a critical assembly concentration of 0.32 mM for the studied conjugate.
• Examines multiple extrinsic factors: molecular design, assembly time, pH, and hydrogen bond inhibitors.
• Proposes a detailed assembly mechanism based on experimental results.

Limitations

• Dataset scope is limited to a single, specifically designed peptide-drug conjugate (Ket-L-VEVE).
• No quantitative sample size, row count, or structured data format (e.g., CSV) is provided in the input.
• Temporal coverage and update frequency are not defined; data reflects a snapshot from a 2020 publication.

Provenance

Source

Dryad digital repository.

Collection Method

Experimental laboratory investigation of peptide-drug conjugate self-assembly.

Freshness

Last updated 2020-06-24.